Seasons And Geographic Locations Strongly Influence Sleep Patterns: Study
Sleep patterns are significantly influenced by the day of the week, the season, and geographic locations, according to a study.
The study, led by researchers from Flinders University in South Australia, is based on data from more than 116,000 adults and over 73 million nights of sleep. The team used an under-mattress device to objectively track sleep duration and timing across 3.5 years, Xinhua news agency reported.
The study finds that sleep is shaped not just by personal habits, but by environmental factors like daylight, temperature, and weekly routines.
"Our findings underscore the seasonal nature of human sleep, and that it is influenced by demographics and geography," said Hannah Scott, a sleep health expert at Flinders University.
People in the Northern Hemisphere sleep 15 to 20 minutes longer in winter, while those in the Southern Hemisphere sleep less in summer.
"Interestingly we found that the farther you live from the equator, the greater the seasonal variation in sleep," Ms. Scott said.
People go to bed later and sleep in longer on weekends, recovering some lost sleep, especially middle-aged adults balancing work and family.
These irregular patterns are increasingly linked to negative health effects, according to the study published in Sleep.
The study found a gradual decline in sleep, with people sleeping about 2.5 minutes less per night from 2020 to 2023, possibly due to the ongoing effects of the Covid-19 pandemic.
"Irregular sleep is more than just feeling tired -- it can be a health risk and understanding how our routines and environments affect sleep is a helpful step towards improving it," said Danny Eckert from Flinders University.
Although the study focused on tech-savvy users and didn't account for factors like pets or partners, it underscores how the environment shapes sleep, reminding people to consider time and season for better rest, said the researchers.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
RFK Jr.'s Dangerous Attack on mRNA Research
Health and Human Services Secretary Robert F. Kennedy Jr. has halted nearly half a billion dollars in funding for mRNA-based respiratory vaccines—and thereby ended America's leadership research into one of modern medicine's most promising frontiers. That verdict runs counter to the evidence. I've spent more than three decades advancing mRNA research. Testing proves it both safe and transformative in the way we fight disease. My work began in the days of basic RNA biology, and it has reached to seeing my graduate student help design the Moderna Covid vaccine. I've watched these discoveries save millions of lives worldwide. Mr. Kennedy's decision must be reversed. The skepticism many Americans have toward mRNA vaccines is easy to understand. The Covid vaccine rollout came with overconfident and misleading assurances that the shots were entirely without risk and that they would prevent infection and transmission. Those claims, delivered with certainty that wasn't backed up by science, proved false. Worse, public-health authorities and employers coupled those messages with sweeping mandates: Take an experimental vaccine or lose your job, your education and access to public spaces. Rather than seeking informed consent, public leaders deployed misinformation and coercive tactics. Being told one thing, then living through another, left a sense of betrayal that damaged the public's trust in health authorities. Acknowledging those errors is mandatory for restoring our credibility. We need to hold two truths at once: The benefits of the Covid vaccine were oversold and the uncertainties understated—and yet, when the data came in, the mRNA vaccines still proved effective at reducing severe illness and death. Here, the evidence is clear. In large, randomized clinical trials reviewed by the FDA, the first mRNA vaccines from Pfizer and Moderna reduced the risk of symptomatic Covid by about 95%. Real-world data from later surges, including the Delta and Omicron waves, confirmed that vaccinated people were far less likely to be hospitalized or die of the virus. The most-discussed adverse event, myocarditis in young men, was real but extremely rare. In the highest-risk group, males age 12 to 17 after a second dose, the risk was roughly 0.006% to 0.011%, about the same as lifetime odds of being struck by lightning. The vaccines were highly effective, and the benefits outweighed the risks by orders of magnitude. That doesn't diminish the experience of anyone who suffered a complication, but it matters when setting national policy. The mRNA vaccines are among the most promising tools in modern medicine. They offer unmatched speed and adaptability, allowing scientists to design and produce targeted vaccines in weeks instead of years. Their potential extends far beyond respiratory diseases. Researchers are now using mRNA to tackle rare genetic disorders, autoimmune diseases, heart disease and cancers. Early trials of customized mRNA vaccines for pancreatic cancer have shown success rates of 50%, echoing the mid-20th-century leukemia breakthroughs that lifted five-year survival from just 10% to 94%. That leap from near-certain death to near-certain survival shows what sustained investment in medical research can achieve. For more than six decades, the U.S. has led the world in biomedical innovation, thanks in large part to sustained federal investment in basic research. That lead is now at risk, as global rivals are moving aggressively to surpass us. Chinese researchers, along with rapidly advancing biotech hubs in other countries, are shortening clinical trial approvals, boosting investment, and attracting record levels of global capital. If we step back, they will seize this field—forcing the U.S. to depend on foreign-made medicines. Once lost, American leadership may never return. American leadership need not, and should not, embrace mRNA technology uncritically. But the government has a responsibility to drive safe, groundbreaking innovation forward. As a scientist whose education was funded by National Institutes of Health grants, I see this as a social contract with the American people. With strong federal backing and a commitment to rapid, responsible progress, mRNA vaccines can realize their full potential. Mr. Coller is a professor of RNA biology and therapeutics at Johns Hopkins University, founder of the Alliance for mRNA Medicines and a co-founder of Tevard Biosciences.
India Today
an hour ago
- India Today
Covid's hidden damage: How the virus is putting women's hearts at risk
There has been a sudden rise in heart diseases, especially among Indian women. Viral videos of women collapsing, dropping dead, young girls collapsing at school have made us wonder, what is going wrong - why are women suddenly getting heart disease?As suspected, Covid-19 is to be blamed.A study, published in the European Heart Journal, indicates that Covid did not just attack lungs, it silently attacked your arteries as well, causing dangerous inflammation and stiffness that can lead to heart attacks, strokes, and lifelong This study was done across 16 countries, involving 2,400 participants, half of which were terrifying? This damage often shows no obvious symptoms at first — just subtle signs like unusual fatigue, chest tightness, or shortness of breath that many dismiss as 'just stress' or 'getting older.'But behind the scenes, women's hearts are being compromised in ways doctors are only beginning to HAS LEFT BEHIND A CARDIOVASCULAR LEGACY: EXPERTSAccording to Dr. Mukesh Goel, senior consultant, cardiothoracic and cardiovascular surgery, heart and lung transplant surgery, Indraprastha Apollo Hospitals, Covid-19 has left behind a cardiovascular legacy that extends well beyond the acute infection."This new study, which highlights that covid-19 may accelerate vascular ageing by up to five years, particularly in women, is deeply significant. Blood vessels are the lifelines of the heart and the body, and their stiffness or premature ageing is closely linked to risks such as hypertension, heart attack, and stroke," Dr. Goel tells India is striking is that women, who were earlier thought to have some natural protection against vascular ageing due to hormones like estrogen, appear to be more vulnerable in the post-covid phase, especially if they suffer from long covid symptoms like breathlessness and Brajesh Kumar Mishra, HOD & consultant, cardiology, Manipal Hospita, adds that one possible reason for this difference between men and women lies in the immune system. Women generally have a faster and stronger immune response, which helps protect them from infections."However, this heightened response can also cause greater damage to blood vessels after the initial infection," Dr. Mishra IS VASCULAR AGEING?Vascular ageing essentially means that the elastic nature of the arteries is reduced, making the heart work harder to pump blood."In a person who has already had Covid-19, this can amplify the risk of heart disease, even in those who were otherwise healthy before infection. It underscores the importance of regular cardiovascular screening for post-covid patients — checking blood pressure, cholesterol levels, blood sugar, and, where needed, vascular health assessments," Dr. Goel agree that Covid-19 was not just a respiratory infection, it affected the heart DISMISS SYMPTOMSadvertisementDismissing symptoms can have long-term consequences for the heart and vascular especially women, must take post-covid symptoms seriously rather than dismiss them as fatigue or lifestyle interventions like a balanced diet, exercise, and medical follow-up can go a long way in mitigating these risks."As physicians, our role is to raise awareness that the pandemic's impact on the heart and blood vessels may unfold silently over years, and vigilance today could prevent major cardiovascular events tomorrow," Dr Goel screening and immediate medical intervention could save the lives of covid-19 patients, particularly women.- EndsTune InMust Watch
Economic Times
an hour ago
- Economic Times
Why more NRIs are buying health insurance in India — not just for their parents, but for themselves
In 2024, over 2.1 million medical tourists visited India seeking treatments ranging from cardiac care to cancer therapies, a number steadily rising post-COVID (Ministry of Tourism, GoI). Among them are not just foreigners, but Indian-origin residents from the US, UK, UAE, and Singapore, many of whom are now insuring not just their ageing parents, but themselves in trend isn't driven by emotion. It's economics, infrastructure, and foresight. According to IRDAI and internal industry trends, there has been a 30–35% increase in health insurance inquiries and purchases by NRIs since 2022. While elder care remains a key trigger, the motivation to insure oneself stems from two realities: Skyrocketing healthcare costs abroad - The WTW Global Medical Trends Survey 2024 reported an average global healthcare inflation of 10.1%, with countries like the US, UK, and Singapore witnessing some of the highest out-of-pocket costs. Exclusions in overseas coverage - Most employer-provided or global health plans do not offer comprehensive protection during India visits, especially for diagnostics, pre-existing conditions, or OPD. The result? A growing number of globally mobile Indians are now turning to India not just as home for the heart, but home for their health. Why India makes sense even for the well-insured abroad Healthcare in India is no longer synonymous with just affordability. It's become globally competitive, technologically advanced, and regulation-backed. Key facts: The Indian healthcare sector is projected to grow to ₹48 lakh crore (~$600 billion) by 2030, according to NITI Aayog and Invest India. Cities like Mumbai, Chennai, Bengaluru, and Hyderabad now boast JCI-accredited and NABH-certified hospitals, on par with global benchmarks. Telemedicine usage has tripled since COVID, with over 10 crore consultations recorded on eSanjeevani (MoHFW, 2024), improving access and continuity of care. The Ayushman Bharat Digital Mission has enrolled over 45 crore citizens, laying the foundation for interoperable digital health records. This infrastructure is not just attracting foreign patients, it's giving NRIs peace of mind when they return, even temporarily. The cost advantage - still unmatched Let's compare real costs (2024–25 averages): Procedure US/UK/UAE India (Top-tier hospitals) MRI Scan ₹45,000–₹60,000 ₹3,000–₹5,000 Knee Replacement Surgery ₹18–22 lakh ₹2.5–3.5 lakh Cardiac Bypass Surgery ₹20–30 lakh ₹2–4 lakh Chemotherapy (per cycle) ₹2.5–3.5 lakh ₹30,000–₹70,000 OPD Consultation (General Physician) ₹5,000–₹10,000 ₹400–₹900 Even with comprehensive global coverage, NRIs are increasingly realising, 'It's cheaper and more efficient to get treated here- if I'm protected.' The vulnerability most NRIs miss Many NRIs assume they're covered in India through: Global insurance plans Travel insurance Employer group coverage But here's the fine print: Travel insurance rarely covers pre-existing conditions, diagnostics, or routine OPD. Employer health plans often exclude treatment outside the country of employment. Claims for India-based treatment are either outright rejected or come with steep deductibles and co-pays. So what happens if an NRI: Develops symptoms while visiting India? Needs follow-up care for a previously treated condition? Has to extend their stay for caregiving or family reasons? That's where a domestic Indian health insurance policy becomes not just a safety net, but a strategic investment. Today's Indian health plans: More NRI-friendly than ever Leading insurers now allow NRIs to: Buy plans online using Aadhaar/passport-based KYC Pay via NRE/NRO accounts or international cards Add OPD, dental, wellness, or second-opinion riders Access 10,000+ hospitals with cashless benefits Include global second opinion features or emergency evacuation options Important: The individual must be physically present in India at the time of purchase. Once the policy is issued, coverage continues even if they return abroad. Affordability: Another win for planning early For NRIs in their 30s or 40s, the premiums are often more affordable than a single hospital co-pay abroad. ₹15 lakh individual health cover (age 35–40): ~₹12,000 to ₹18,000/year ₹25 lakh family floater plan for NRI + parent: ~₹28,000–₹35,000/year Some insurers also offer 'No Claim Bonuses up to 100–150%', making the cover more rewarding over time. A sign of intent: Not just for now, but for later For many NRIs, buying health insurance in India is about more than managing the risk of falling sick during a trip. It's a future-proofing step for: Remote work or return-to-India plans Caring for elderly parents for extended durations Retirement in India Running dual households across geographies It also helps maintain continuity of coverage, avoiding the burden of fresh underwriting if and when one decides to move back permanently. Where you heal matters as much as where you live In a world where geography no longer defines identity, the smartest Indians are building cross-border safety nets. Health insurance in India is no longer an afterthought, it's becoming a parallel pillar of global protection. Because when life takes an unexpected turn, a sudden illness, a family emergency, a career shift, it helps to know you're covered, not just where you reside, but where you feel at sometimes, that place… is still called India. (Disclaimer: The opinions expressed in this column are that of the writer. The facts and opinions expressed here do not reflect the views of (Join our ETNRI WhatsApp channel for all the latest updates) Elevate your knowledge and leadership skills at a cost cheaper than your daily tea. Hacking, ransom, lawsuits: Why social engineering is TCS, Cognizant's latest headache Govt easing policies to boost growth; when will industry play ball? Can new shipping laws bury the ghost of British legacy? How IDBI banker landed plush Delhi properties in Amtek's INR33k crore skimming Stock Radar: M&M hits fresh record high in August 2025; time to buy or book profits? Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports Plus F&O Radar | Deploy Bull Call Spread in Nifty to play index reversal Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 20% in 1 year
